IPAR vs UTHR · P/E 17, rev $1.32B vs P/E 20, rev $2.88B
Inter Parfums Inc (IPAR) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Inter Parfums Inc (IPAR) is a household & personal products company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported IPAR revenue for 2023-12-31 was $1.32B. Net income was $187.8M. Revenue was up 21.3% from 2022-12-31 to 2023-12-31. IPAR currently screens at market cap $2.92B and trailing P/E 17.3.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
IPAR currently screens at market cap $2.92B and trailing P/E 17.3. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the IPAR and UTHR stock pages for the full models.
Not investment advice.